Hot Features
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac diseas... Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.045 | 16.2834224599 | 18.7 | 22.385 | 18.3 | 900264 | 21.00690977 | CS |
| 4 | 4.695 | 27.5366568915 | 17.05 | 22.385 | 15.51 | 420470 | 19.38462554 | CS |
| 12 | -7.395 | -25.377487989 | 29.14 | 35.7999 | 15.51 | 356689 | 24.70418321 | CS |
| 26 | -5.475 | -20.1138868479 | 27.22 | 35.7999 | 15.51 | 283906 | 26.39917283 | CS |
| 52 | 9.035 | 71.0857592447 | 12.71 | 35.7999 | 9.1 | 189487 | 23.84169276 | CS |
| 156 | 20.705 | 1990.86538462 | 1.04 | 35.7999 | 0.2796 | 141106 | 16.24844242 | CS |
| 260 | -13.155 | -37.6934097421 | 34.9 | 36.85 | 0.2796 | 255906 | 9.18446039 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.